Incannex Healthcare Ltd
ASX:IHL
Incannex Healthcare Ltd
ASX:IHL
Price:
0.041
AUD
Market Closed
Market Cap:
AU$43.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Incannex Healthcare Ltd
ASX:IHL
|
AU |
|
Episurf Medical AB
STO:EPIS B
|
SE |
|
H
|
HDFC Bank Ltd
F:HDFA
|
IN |
|
H
|
Hengdian Entertainment Co Ltd
SSE:603103
|
CN |
|
F
|
Flowing Cloud Technology Ltd
HKEX:6610
|
CN |
|
Rail Vikas Nigam Ltd
NSE:RVNL
|
IN |
|
S
|
Sunshine Agri Tech Inc
XTSX:SAI.H
|
CA |
|
Linamar Corp
TSX:LNR
|
CA |
|
Daikokuya Holdings Co Ltd
TSE:6993
|
JP |
|
Tega Industries Ltd
NSE:TEGA
|
IN |
|
CrowdStrike Holdings Inc
BMV:CRWD
|
US |
|
Hoe Leong Corporation Ltd
SGX:H20
|
SG |
|
C
|
COSCO SHIPPING Ports Ltd
OTC:CSPKY
|
HK |
|
Z
|
Zinus Inc
KRX:013890
|
KR |
|
Tamboran Resources Corp
NYSE:TBN
|
AU |
|
M
|
MDC Holdings Inc
LSE:0JW5
|
US |
|
E
|
Endeavour Silver Corp
NYSE:EXK
|
CA |
|
Marvell Technology Group Ltd
NASDAQ:MRVL
|
US |
|
Inscobee Inc
KRX:006490
|
KR |
|
L
|
Leader Steel Holdings Berhad
KLSE:LSTEEL
|
MY |
|
Rupa & Company Ltd
NSE:RUPA
|
IN |
|
Z
|
Zedge Inc
AMEX:ZDGE
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of IHL.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IHL
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
IHL Competitors Multiples
Incannex Healthcare Ltd Competitors
Incannex Healthcare Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Incannex Healthcare Ltd
ASX:IHL
|
43.3m AUD | 31.4 | -2.2 | -0.5 | -0.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
